Follicular lymphoma is the second most common sub-type of non-Hodgkin’s lymphoma. Although rarely considered curable, this indolent lymphoma typically follows a...
Treatment regimens involving the monoclonal anti-CD20 antibody rituximab are the standard of care for patients with CD20-positive non-Hodgkin lymphoma (NHL). It has...
Non-Hodgkin’s lymphoma is a heterogeneous group of lymphoproliferative malignancies with differing patterns of behaviour and responses to treatment. Chemotherapy,...
While some cancers get a great deal of media coverage, lymphoma is something of the poor relation, although there are about 11,000 new cases a year in the UK. Gill...